Average Co-Inventor Count = 3.80
ph-index = 13
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Columbia University (18 from 2,487 patents)
2. Sloan-kettering Institute for Cancer Research (16 from 512 patents)
3. Schering Corporation (2 from 1,829 patents)
4. Other (1 from 832,680 patents)
5. Memorial Sloan Kettering Cancer Center (1 from 559 patents)
6. Research, Incorporated (1 from 444 patents)
7. The Trustees of Columbia (1 from 1 patent)
27 patents:
1. 10626100 - Selective HDAC6 inhibitors
2. 9890136 - Selective HDAC6 inhibitors
3. 9499479 - Molecules that selectively inhibit histone deacetylase 6 relative to histone deacetylase 1
4. 7799803 - Hydroxamic acid compounds and methods of use thereof
5. 7345174 - Cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
6. 7199134 - Hydroxamic acid compounds and methods of use thereof
7. 7126001 - Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
8. 7124068 - Crystal structure of a deacetylase and inhibitors thereof
9. RE38506 - Potent inducers of terminal differentiation and methods of use thereof
10. 6511990 - Class of cytodifferentiating agents and histone deacetylase inhibitors, and methods of use thereof
11. 6331530 - Hydrophilic carrier for photosensitizers that cleaves when they catalyze the formation of singlet oxygen
12. 6103892 - Catalyst that oxidizes steroids and other substrates with catalytic
13. 6093812 - Process for the stereospecific synthesis of azetidinones
14. 6087367 - Potent inducers of terminal differentiation and methods of use thereof
15. 5932616 - Potent inducers of terminal differentiation and methods of use thereof